BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rössle M, Bettinger D, Trebicka J, Klinger C, Praktiknjo M, Sturm L, Caca K, Mücke VT, Radecke K, Engelmann C, Zipprich A, Heinzow H, Meyer C, Tappe U, Appenrodt B, Schmidt A, Lange C, Strassburg C, Zeuzem S, Grandt D, Schmidt H, Moessner J, Berg T, Lammert F, Thimme R, Schultheiß M. A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment. Aliment Pharmacol Ther 2020;52:329-39. [PMID: 32506456 DOI: 10.1111/apt.15811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Schultheiß M, Bettinger D, Thimme R, Rössle M. 30 Jahre transjugulärer intrahepatischer portosystemischer Shunt (TIPS) – Rückblick und Perspektive. Z Gastroenterol 2020;58:877-89. [DOI: 10.1055/a-1217-7866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Benmassaoud A, Rodger M. Challenging anticoagulation cases: Acute extensive portal vein thrombosis in a patient without cirrhosis - Evidence-based management of a rare clinical entity. Thromb Res 2021;206:133-6. [PMID: 34464871 DOI: 10.1016/j.thromres.2021.08.013] [Reference Citation Analysis]
3 Meine TC, Becker LS, Dewald CLA, Maschke SK, Maasoumy B, Jaeckel E, Wedemeyer H, Wacker FK, Meyer BC, Hinrichs JB. Percutaneous Transsplenic Balloon-Assisted Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Portal Vein Obliteration for Portal Vein Recanalization: Feasibility, Safety and Effectiveness. Cardiovasc Intervent Radiol 2022. [PMID: 35018502 DOI: 10.1007/s00270-021-03054-2] [Reference Citation Analysis]
4 Zhang D, Xu S, Tian Y, Qi X. Editorial: acute non-cirrhotic and non-malignant portal vein thrombosis-who should be candidates for interventional treatment? Aliment Pharmacol Ther 2020;52:725-8. [PMID: 32886391 DOI: 10.1111/apt.15902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ju C, Li X, Gadani S, Kapoor B, Partovi S. Portal Vein Thrombosis: Diagnosis and Endovascular Management. Rofo 2021. [PMID: 34649289 DOI: 10.1055/a-1642-0990] [Reference Citation Analysis]
6 Brichard M, Iesari S, Lerut J, Reding R, Goffette P, Coubeau L. Meso-Rex bypass for the management of extrahepatic portal vein obstruction in adults (with video). Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00159-4. [PMID: 34426078 DOI: 10.1016/j.hbpd.2021.08.003] [Reference Citation Analysis]
7 Sturm L, Bettinger D, Klinger C, Krauss T, Engel H, Huber JP, Schmidt A, Caca K, Thimme R, Schultheiss M. Validation of color Doppler ultrasound and computed tomography in the radiologic assessment of non-malignant acute splanchnic vein thrombosis. PLoS One 2021;16:e0261499. [PMID: 34929009 DOI: 10.1371/journal.pone.0261499] [Reference Citation Analysis]
8 Mansour N, Öcal O, Gerwing M, Köhler M, Deniz S, Heinzow H, Steib C, Angele MK, Seidensticker M, Ricke J, Wildgruber M. Interventional recanalization therapy in patients with non-cirrhotic, non-malignant portal vein thrombosis: comparison between transjugular versus transhepatic access. Abdom Radiol. [DOI: 10.1007/s00261-022-03411-w] [Reference Citation Analysis]
9 Riva N, Ageno W. Direct oral anticoagulants for unusual-site venous thromboembolism. Res Pract Thromb Haemost 2021;5:265-77. [PMID: 33733025 DOI: 10.1002/rth2.12480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rössle M, Bettinger D, Thimme R, Schultheiss M. Editorial: acute non-cirrhotic and non-malignant portal vein thrombosis--who should be candidates for interventional treatment? Authors' reply. Aliment Pharmacol Ther 2020;52:729-30. [PMID: 32886377 DOI: 10.1111/apt.15930] [Reference Citation Analysis]
11 Zanetto A, Barbiero G, Battistel M, Sciarrone SS, Shalaby S, Pellone M, Battistella S, Gambato M, Germani G, Russo FP, Burra P, Senzolo M. Management of portal hypertension severe complications. Minerva Gastroenterol (Torino) 2021;67:26-37. [PMID: 33140623 DOI: 10.23736/S2724-5985.20.02784-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]